![]() Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. | ![]() Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. | ![]() Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. | |
Founding Date | Founding Date 2018 | Founding Date 2017 | Founding Date 2009 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Carlsbad, US HQ | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB |
Employees | Employees 8510% decrease | Employees 54 | Employees 3716% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 313.1 m | Valuation ($) 131.4 m |
Financial | |||
Net income | Net income N/A | Net income ($69.8m) (FY, 2025) | Net income (kr58m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 415m | Total funding raised $ 45m | Total funding raised N/A |

Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View company
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View company